Cancer Research and the 70 kDa Ribosomal Protein S6 Kinase Market

toegevoegd een audio Health

2026-10-30 09:53:26 - Translate -

Cancer research is the largest application segment of the p70S6K market. The enzyme sits downstream of mTOR, a central regulator of cell growth, and is frequently hyperactivated in tumours. Inhibiting p70S6K is a promising strategy for cancers driven by mTOR pathway mutations, and p70S6K expression levels serve as biomarkers for prognosis and treatment response. As oncology research investment...

0 Reacties 0 aandelen 130 Views 0 voorbeeld